Literature DB >> 3385642

Nonlinear pharmacokinetics of aspirin in rats.

M G Wientjes1, G Levy.   

Abstract

Rats are frequently used as an animal model for studies of the antithrombotic action of aspirin. The purpose of this investigation was to explore factors that influence the systemic exposure to unhydrolyzed aspirin after oral and systemic administration of the drug to adult male Sprague-Dawley rats. The experiments were performed according to a crossover design, and drug concentration measurements were made on whole blood. Intravenous injection and oral administration of aspirin (200 mg/kg) showed that the drug is eliminated rapidly (total clearance approximately 45 ml/min/kg; half-life approximately 8 min), that only about one-fourth of the dose is absorbed intact, and that the systemic availability of the oral dose is highly variable (coefficient of variation approximately 60%). A 40 mg/kg i.v. dose was cleared almost twice as rapidly as a 200 mg/kg i.v. dose. Injection of salicylic acid to yield concentrations similar to those obtained after injection of the large dose of aspirin (approximately 400 mg/l) reduced the total clearance of a 40 mg/kg i.v. dose of aspirin by about one-third, suggesting product inhibition of ester hydrolysis. The systemic availability of aspirin infused into the portal circulation was about 80% over a wide range of infusion rates, showing that presystemic hydrolysis of the drug occurs mainly in the gut. As in humans, absorption of orally administered aspirin affects the exponential decline of aspirin concentrations in blood, resulting in an apparent half-life substantially longer than the actual biologic half-life of the drug after i.v. injection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385642

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites.

Authors:  Mireille Basselin; Epolia Ramadan; Mei Chen; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2010-10-28       Impact factor: 3.996

2.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

3.  The pharmacokinetics of aspirin in rats and the effect of buffer.

Authors:  C J Fu; S Melethil; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

4.  Pharmacokinetics and pharmacodynamics in copper deficiency. I. Antiinflammatory activity of aspirin.

Authors:  A Lopez-Anaya; C Dawson; C Gonzales; M Bacolod; V Kishore
Journal:  Biol Trace Elem Res       Date:  1994-02       Impact factor: 3.738

5.  New approaches for the assessment of platelet activation status in thrombus under flow condition using confocal microscopy.

Authors:  Natalia Marcinczyk; Agata Golaszewska; Tomasz Misztal; Anna Gromotowicz-Poplawska; Tomasz Rusak; Ewa Chabielska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-13       Impact factor: 3.000

6.  The Intake of Coffee Increases the Absorption of Aspirin in Mice by Modifying Gut Microbiome.

Authors:  Jeon-Kyung Kim; Min Sun Choi; Hye Hyun Yoo; Dong-Hyun Kim
Journal:  Pharmaceutics       Date:  2022-03-30       Impact factor: 6.525

Review 7.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.